|
Men's Health
|
|
|
SAN FRANCISCO – MDV3100, new oral inhibitor of androgen receptor signaling, reduces the risk of death by more than a third after a failure of docetaxel chemotherapy in men with progressive castration-resistant prostate cancer, according to results of the randomized AFFIRM trial. Interim data for... »
Most Americans aged 75 years and older continue to undergo routine screening for breast, cervical, colorectal, or prostate cancer even though recommendations advise against it, according to a report in the Dec. 12/26 issue of Archives of Internal Medicine. Approximately half of these older adults... »
CHICAGO – Multiparametric magnetic resonance imaging trumped national guidelines in correctly classifying patients with prostate cancer as candidates for active surveillance in a retrospective study of 126 men. National Comprehensive Cancer Network (NCCN) guidelines misclassified 22 of the 126... »
Interested in being notified of new Men's Health news?
Click here to view our Men's Health RSS Feed.
| Feb 5 - 12 Departs Ft. Lauderdale, FL | Preventive Medicine |
| Feb 6 - 11 Dallas, TX | Society for Maternal-Fetal Medicine (SMFM): Annual Meeting (The Pregnancy Meeting) |
| Feb 6 - 10 Sarasota, FL | Rheumatology: Improving Primary Care Outcomes Through Diagnosis and Treatment |
| Feb 7 - 11 San Francisco, CA | American Academy of Orthopaedic Surgeons (AAOS): Annual Meeting |
| Feb 8 - 12 Naples, FL | Dermatology Foundation (DF): Clinical Symposia |
| Feb 8 - 11 Barcelona, | International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) |
| Feb 8 - 10 San Diego, CA | American Academy of Emergency Medicine (AAEM): Annual Scientific Assembly |
| Feb 9 - 11 New York, NY | Integrative Healthcare Symposium |
| Feb 9 - 11 New Orleans, LA | American Federation for Medical Research (AFMR): Southern Regional Meeting |
| Feb 12 - 15 Freiburg, | German Society for Thoracic and Cardiovascular Surgery: 41st Annual Meeting |